1-3 of 3
Christopher N Graham
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cost-Effectiveness of Daratumumab Plus Bortezomib and Dexamethasone Versus Bortezomib Plus Dexamethasone for Treatment of Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy: An Analysis of the Castor Trial

Eric M Maiese, Christopher N Graham, Emma Hawe, Jean-Gabriel Le Moine, Ivo Abraham, PhD RN, Mekre Senbetta
Journal: Blood
Blood (2017) 130 (Supplement 1): 3400.
https://doi.org/10.1182/blood.V130.Suppl_1.3400.3400
Published: 2017
Journal Articles

Cost-Effectiveness of Daratumumab Plus Lenalidomide Plus Dexamethasone Versus Lenalidomide Plus Dexamethasone for Treatment of Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy: An Analysis of the Pollux Trial

Eric M Maiese, Christopher N Graham, Emma Hawe, Jean-Gabriel Le Moine, Ivo Abraham, PhD RN, Mekre Senbetta
Journal: Blood
Blood (2017) 130 (Supplement 1): 4711.
https://doi.org/10.1182/blood.V130.Suppl_1.4711.4711
Published: 2017
Journal Articles

Economic Comparison Of Treating Hemophilia Patients Who Have Developed Inhibitors Via Immune Tolerance Induction Versus Prophylaxis and On-Demand Treatment With Bypassing Agents

Stephanie R. Earnshaw, PhD, Cheryl L. McDade, Christopher N. Graham, MS, Jeffrey B. Spears, PharmD, Craig M. Kessler, MD
Journal: Blood
Blood (2013) 122 (21): 422.
https://doi.org/10.1182/blood.V122.21.422.422
Published: 2013